Moteur de recherche d’entreprises européennes
Financement de l’UE (2 540 146 €) : Big Data in Chemistry Hor11/08/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Big Data in Chemistry
The advent of the big data era in chemistry and the life sciences requires the development of new computational analysis methods, which are not only of scientific, but also economic relevance. Currently, the international data market already grows six times faster than the entire IT sector, and growth rates further increase. Achieving and sustaining a leadership positions in the big data arena represent critically important challenges for the EU. The economic developments in the emerging big data field are science-driven. Due to complexity and heterogeneity of biochemical and biomedical data, large-scale data exploration and exploitation are intrinsically interdisciplinary tasks. BIGCHEM positions itself at interfaces between chemistry, computer science, and the life science to provide well-structured multidisciplinary training and educate high-in-demand computational specialists capable of operating in interdisciplinary and international research and business settings. Cornerstones of BIGCHEM’s curriculum include on-line lectures and periodic schools taught by internationally leading experts in chemical and life science informatics, a balanced consortium of academia, SMEs, and large industry, and an unprecedented symbiosis of academic and industrial training and application components. Accordingly, BIGCHEM is well positioned to boost multilateral collaborations between academia and industry and train scientists who are highly competitive in the international big data market. In BIGCHEM’s R&D and training activities, the development and evaluation of conceptually novel methods for large-scale data analysis, knowledge extraction, and information sharing with demonstrated practical application potential take center stage. The network has a clearly defined policy for exploitation of new IP through wide involvement of target users, SMEs, and large industry facilitated by the experienced technology transfer department of the coordinator's team.
| Chemotargets SL | ? |
| Astrazeneca AB | 703 092 € |
| BOEHRINGER INGELHEIM PHARMA GmbH & Co. KG | 463 820 € |
| EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH | 132 613 € |
| HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GmbH | 249 216 € |
| LEAD DISCOVERY CENTER GmbH | 124 608 € |
| RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN | 443 052 € |
| Universita Degli Studi Di Modena E Reggio Emilia | 86 020 € |
| UNIVERSITAET BERN | 206 287 € |
| Universite de Strasbourg | 131 438 € |
https://cordis.europa.eu/project/id/676434
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Chemotargets SL, Barcelona, Espagne.
